1Adler SG, Pahl M, Seldin MF.Deciphering diabetic nephropathy: progress using genetic strategies.Curr Opin Nephrol Hypertens,2000,9:99-106.
2Lansang MC, Hollenberg NK.Renal perfusion and the renal hemodynamic response to blocking the renin system in diabetes: are the forces leading to vasodilation and vasoconstriction linked?Diabetes,2002,51:2025-2028.
3Volker V, Roland CB, Scott T, et al. Glomerular hyperfiltration and the salt paradox in rarly type 1 diabetes mellitus: a tubulo-centric view. J Am Soc Nephrol, 2003,14:530-537.
4Sheetz MJ, King GL.Molecular understanding of hyperglycemia's adverse effects for diabetic complications.JAMA,2002,288:2579-2588.
5Brownlee M. Biochemistry and molecular cell biology of diabetic complications.Nature,2001,414:813-820.
6Forbes JM, Cooper ME, Thallas V, et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.Diabetes,2002,51:3274-3282.
7Evans JL, Goldfine ID, Maddux BA,et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev, 2002,23:599-622.
8White KE, Bilous RW, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria.Diabetes,2002,51:3083-3089.
9Batlle D. Clinical and cellular markers of diabetic nephropathy.Kidney Int,2003,63:2319-2330.
10Kveder R, Kajtna-Koselj M, Rott T, et al. Nephrotic syndrome in patients with diabetes mellitus is not always associated with diabetic nephropathy.Nephrol Dial Transplant,2001,16 Suppl 6:86-87.
